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Abstract
Background: Minimally invasive surgical treatment of lone atrial fibrillation (AF) is an alternative for AF that is
refractory to medical treatment. We present long-term results of standalone surgical ablation of AF using a
bipolar ablation device in 91 consecutive patients.
Methods: This was an observational, retrospective study of 91 patients (77 % males; mean age, 53 ± 10 years
[range, 23–75 years]) who underwent minimally invasive standalone surgical ablation of persistent and longstanding
persistent AF using a bipolar ablation device from 2008 to 2014. Mean follow-up was 60 ± 21 months. The absence
of arrhythmia was confirmed at 3, 6, and 12 months, and annually thereafter, with 24-hour Holter monitoring.
Results: The mean duration of preoperative AF was 6.5 ± 5.4 years. Persistent AF was present in 86 % of patients
and longstanding persistent AF in 14 %. Mean left atrial diameter was 4.3 ± 0.8 cm. There were two postoperative
strokes (2 %) and three conversions to median sternotomy (3 %). Permanent pacemakers were implanted in six
(7 %) patients. There were no intra- or postoperative deaths. At 1, 2, 3, 4, and 5 years postoperatively, freedom
from AF was 59, 45, 41, 38, and 38 % of patients, respectively. The failure to achieve pulmonary vein isolation was
the only independent predictor of long-term recurrence of AF (HR −3 [95 % CI 1,858 to 8,586], p = 0,001). There
was a tendency towards higher rates of SR at long term follow up in patients with pulmonary vein isolation if
division of ligament of Marshall was performed (HR - 2 [95 % CI 0.987 to 4,202], p = 0,067).
Conclusions: In the present series, the efficacy of epicardial surgical ablation was similar to that reported
previously. The rate of arrhythmia recurrence increased over time. Achieving pulmonary vein isolation is
essential to AF elimination. The division of ligament of Marshall could contribute to improved rates of SR
restoration in patients with persistent or long-standing persistent AF if PVI is achieved.
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Background
Surgery is a recognized treatment option for patients
with atrial fibrillation (AF) [1–3]. Recent guidelines
representing collective experience have become more
liberal in patient selection for surgical treatment of lone
AF [2]. The 2012 HRS/ EHRA/ECAS Expert Consensus
Statement on Catheter and Surgical Ablation of Atrial
Fibrillation [2] allows consideration of surgical interven-
tion to treat AF if a patient prefers surgical ablation,
even without failed catheter ablation. Thus, surgical
treatment for lone AF has increased [4].
Some centers report excellent long-term results, with
freedom from AF in up to 85 % of patients [4–6]. How-
ever, in a systematic review of minimally invasive surgi-
cal treatment for AF by Je et al., most of the included
studies presented data for a mean follow-up of about
2 years [7]. We report the single-center, long-term re-
sults of bi-atrial minimally invasive surgical ablation of
lone AF with a bipolar radiofrequency ablation device.
Methods
This was an observational, retrospective study. From
2008 to 2014, 91 patients underwent video-assisted
standalone bipolar radiofrequency ablation for non-
valvular persistent or longstanding persistent AF at
our institution. Indications for procedures were: AF
burden (European Heart Rhythm Association [2] class
III–IV), ineffective medical treatment, and patient’s
preference to undergo surgical intervention [2]. Per
recent guidelines, we defined AF as persistent, or
longstanding persistent [1]. The same surgeon per-
formed all procedures. The surgical technique was the
same for all patients and included a persistent attempt
to achieve pulmonary vein isolation (PVI) after the
importance of PVI was noted in initial patient group.
A bipolar radiofrequency clamp (Cardioblate® Gemini®
Surgical Ablation System; Medtronic, Inc., Minneapolis,
MN, USA) was used in all cases.
Surgical technique
Patient positioning and anesthesia
The patient was positioned supine with the arms at the
sides. A foam roll approximately 5 cm in diameter was
placed under the shoulders to improve exposure. Gen-
eral anesthesia with a double-lumen endotracheal tube
was used for the procedure. Routine cardiac monitoring
was conducted throughout the procedure, including
electrocardiography and invasive radial arterial and cen-
tral venous pressures. A Foley catheter was placed to
monitor diuresis. External defibrillation pads were rou-
tinely placed. Transesophageal echocardiography (TEE)
was used to rule out thrombus of the atrial appendage
and to evaluate the quality of its closure.
Right-side access
Single-lung ventilation of the left lung was established.
A 4-cm thoracotomy incision was performed at the 4th
intercostal space between the anterior and midaxillary
lines. The layers were dissected and the parietal pleura
opened. A pericardiotomy was performed 1–2 cm anter-
ior to the phrenic nerve. The heart was pulled closer to
the incision with retraction sutures, which were left on
clips. The oblique pericardial sinus was entered using
blunt dissection between the inferior pulmonary vein
and the inferior vena cava. A gastric probe was pushed
between the inferior pulmonary vein and the inferior
vena cava. The pericardial reflection between the super-
ior pulmonary vein and superior vena cava was dis-
sected. A Navigator® Tissue Dissector (Medtronic, Inc.)
was introduced and pushed between the superior right
pulmonary vein and the superior vena cava to enter the
transverse sinus. A guidewire was pushed into the trans-
verse sinus, and the tissue dissector was removed, leav-
ing the guidewire in place. Tension on the pericardial
retraction sutures was released.
Left-side access
A 5-cm thoracotomy incision was performed in the 3rd
intercostal space between the anterior and midaxillary
lines. Single-lung ventilation of the right lung was estab-
lished. The layers were dissected and the parietal pleura
opened. A pericardiotomy was performed 1–2 cm pos-
terior to the phrenic nerve. The heart was pulled closer
to the incision with retraction sutures, which were left
on clips. The guidewire and gastric tube, which had been
pushed in from the right side, were pulled, leaving them
on the posterior surface of the heart, above and below
the pulmonary veins.
The plastic guides included in the Cardioblate® Gem-
ini® Surgical Ablation System set (Medtronic, Inc.) were
pulled out using the gastric tube and guidewire. One
plastic guide was left above the pulmonary veins and
another below the pulmonary veins. The bipolar radio-
frequency ablation clamp from the Cardioblate® Gemini®
Surgical Ablation System was positioned. After a series
of three ablations, the direction of the bipolar ablation
device was changed and a second series of three abla-
tions was performed from another side of the chest.
After the procedure, exit block of the PVI box created
by the ablation lines was checked in all cases. Each pul-
monary vein above the ablation line was paced with a
rate higher than the patient’s heart rate, and 20-mA
stimuli were used to confirm exit block. The standard
ablation with three applications from left and right heart
sides did not succeed in achieving PVI in 35 (38 %)
patients. If PVI was not achieved, individual ablation of
each of the four pulmonary veins was performed. This
was performed in 24 (26 %) of our patients.
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Right atrial ablation
After PVI was achieved, right atrial ablation was per-
formed. The ablation lines are showed in Fig. 1. Using
the bipolar ablation device, additional lines were created
on the right atrium: a longitudinal line from the right
atrium appendage targeting the intraatrial septum be-
tween the right pulmonary veins; a line from the lateral
part of the right atrium toward the tricuspid valve annu-
lus; and a circular line at the ostium of the inferior vena
cava. These ablation lines were targeting cavotricuspid
isthmus. Although there are numerous evidences show-
ing triggers coming from superior vena cava, superior
vena cava was not ablated to avoid damage to sinus
node. Linear block after ablation has not been checked.
Additional procedures
Ligation of the left atrial appendage and division of liga-
ment of Marshall. Ligation of left atrial appendage was
performed with 2/0 polyester suture using knot pusher.
Two ligatures were placed: one at the basis of the atrial
appendage, another – about 7 mm distally from the first
ligature. End of atrial appendage was cut to evacuate re-
sidual blood from appendage and check ligation quality.
Postoperative care and follow-up
Clinical demographic and postoperative outcome vari-
ables were collected retrospectively and prospectively.
Anticoagulation with warfarin was initiated in all pa-
tients in the early postoperative period. Class I (propafe-
none), class II (beta blockers), or class III (amiodarone,
sotalol, dronedarone) antiarrhythmic drugs (AADs) were
initiated if arrhythmias were noted during the postopera-
tive course. Patients with postoperative atrial tachyar-
rhythmias were electrically cardioverted if medical
conversion was not effective. If patients were in SR and
free of atrial tachyarrhythmias on prolonged monitoring
(≥6 months) after the procedure, AADs were discontin-
ued. If CHA2DS2-VASc score was less than 2, warfarin
was discontinued. TEE was performed before discon-
tinuation of warfarin to rule out atrial thrombus. Follow-
up was conducted at 3, 6, and 12 months and annually
thereafter. At each visit, history, physical examination,
electrocardiogram, and 24-hour Holter monitoring or
pacemaker interrogation were obtained. 24-hour Holter
monitoring was not performed on 3-month follow up
and if patient had arrhythmia on ECG. There were 222
Holter monitoring’s performed in reported patient
group, and 27 (12 %) of them have revealed silent
arrhythmia. Recurrence was defined as any episode of
AF, atrial flutter, or atrial tachycardia that lasted longer
than 30 s [8, 9]. Episodes of AF or atrial flutter were
treated with AADs, electrical cardioversion, or catheter
ablation using a CARTO® Thermocool Catheter (Bio-
sense Webster, Inc.; Diamond Bar, CA, USA). Treatment
was considered successful only if the patient was free of
AF and off class I or class III AADs.
Statistical analysis
Categorical variables are presented as proportions and
were compared with Pearson’s χ2 test and Fisher’s exact
test. Normally distributed continuous variables are
expressed as means ± SD and were compared with
Student’s unpaired t-test. Non-normally distributed
continuous variables were expressed median and range
and were compared with Mann–Whitney U-test.
Kaplan-Meier method was used to estimate arrhythmia
and AAD free survival. Log rank test was used to com-
pare Kaplan-Meier curves. Univariate and multivariate
predictors of recurrent AF were evaluated using Cox
proportional hazards regression model. Variables were
included in the multivariable analysis using a forward
stepwise procedure with criteria of P < 0,05 for inclu-
sion and P > 0,10 for removal from the model. All re-
ported P values were two-sided. A value of P < 0,05 was
considered to indicate statistical significance. A value of
0,05 < P < 0,1 was considered to indicate tendency. IBM
SPSS for Macintosh software, Version 20.0 (IBM Corp.,
Armonk, NY, USA) was used for statistical analyses.
Results
Patient characteristics, including sex and mean age, as
well as preoperative clinical data, including distribution
of type and mean duration of AF, atrial dimensions,
ablation history, and comorbidities, are presented in
Fig. 1 Ablation lines. Pulmonary vein isolation (1); right atrial ablation:
line from the RAA targeting the intraatrial septum between the right
pulmonary veins (2); line from the lateral part of the right atrium
toward the TV annulus (3); circular line at the ostium of the inferior
vena cava (4); ligation of the left atrial appendage (5). LAA left atrial
appendage, MV mitral valve, PV pulmonary veins, RAA right atrial
appendage, SVC superior vena cava, TV tricuspid valve
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Table 1. The average patient age was 53 years, range
23–75 years. Twenty-one percent of patients had failed
a previous catheter ablation, and 17 (19 %) had thyroid
dysfunction due to amiodarone use. Patients with long
standing persistent AF had longer AF duration and
larger left atria. There were no other significant differ-
ences between those patient groups (Table 1).
Median operative duration was 180 (range, 90–
280 min). PVI was achieved in 88 % of patients and
proven by checking for exit block. In 24 (26 %) of pa-
tients, PVI of each pulmonary vein was performed.
Table 1 presents intraoperative details.
In one patient it was impossible to perform PVI with
the available equipment, as there was ST-segment
depression and a significant drop in blood pressure as
soon as the pulmonary veins were clamped. Postoper-
ative contrast-enhanced computed tomography sug-
gested that the left main stem might have become
compressed during application of the bipolar ablation-
device clamps.
Left atrial appendage was not excluded in one patient.
The patient had fragile tissues, LA appendage was short
with wide base, and it was surgeon’s decision to abandon
atrial appendage ligation to avoid risk of bleeding.
Median stay in the intensive care unit was 1 day
(range, 1–7 days), and median length of hospitalization
was 12 days (range, 2–32 days). There were two postop-
erative strokes (2 %) and three conversions to median
sternotomy (3 %): one because of damage to the pul-
monary artery, one because of damage to the left atrial
appendage, and one in the intensive care unit because of
tamponade caused by bleeding from the surface of the
right ventricle. One wound revision was required
because of bleeding into soft tissues. One patient (1 %)
developed a superficial wound infection. Three patients
(3 %) required early postoperative permanent pacemaker
Table 1 Patient characteristic
Overall (N = 91) Persistent AF (N = 78) Long standing persistent AF (N = 13) P value
Follow up (months) 60 ± 21 60 ± 21 63 ± 19 0.569
Age (years) 53 ± 10 53 ± 9 52 ± 11 0.661
Patients < 65 years old 80 (87 %) 69 (89 %) 11 (85 %) 0.694
Patients 65–74 years old 10 (11 %) 8 (10 %) 2 (15 %) 0.631
Patients > 65–74 years old 1 (1 %) 1 (1 %) 0 (0 %) 1.000
Female gender 21 (23 %) 19 (24 %) 2 (15 %) 0.726
LV dysfunction 11 (12 %) 8 (10 %) 3 (23 %) 0.189
Hypertension 73 (80 %) 62 (80 %) 11 (85 %) 1.000
Diabetes Mellitus 5 (6 %) 4 (5 %) 1 (8 %) 0.546
History of TIA 5 (5 %) 4 (8 %) 1 (8 %) 1.000
Stroke on adequate anticoagulation 2 (2 %) 2 (2 %) 0 (0 %) 1.000
Peripheral vascular disease 4 (4 %) 4 (5 %) 0 (0 %) 1.000
CHA2DS2-VASc Score = 0 9 (10 %) 8 (10 %) 1 (8 %) 0.774
CHA2DS2-VASc Score = 1 47 (52 %) 40 (51 %) 7 (54 %) 0.864
CHA2DS2-VASc Score ≥2 35 (38 %) 30 (38 %) 4 (30 %) 0.596
AF duration (months) 73 ± 66 40 ± 37 79 ± 69 0.006
Failed catheter ablation 10 (21 %) 17 (22 %) 2 (15 %) 0.598
Failed catheter ablation >1 time 9 (10 %) 7 (10 %) 2 (15 %) 0.474
Median LVEF (%) 55 (30–65) 55 (30–65) 55 (40–55) 0.293
LA diameter (cm) 4.3 ± 0.5 4.2 ± 0.5 4.7 ± 0.4 0.046
Operative
Median operation duration (min) 180 (90–280) 180 (90–280) 170 (120–240) 0.497
Ablation time (min) 14 ± 4 13 ± 4 15 ± 6 0.772
PV Ablation time (min) 10 ± 3 10 ± 3 10 ± 5 0.864
RA Ablation time (min) 5 ± 3 6 ± 4 4 ± 2 0.293
Division of ligament of Marshall 61 (67 %) 55 (71 %) 6 (46 %) 0.112
Box lesion around PVs (exit block achieved) 80 (88 %) 70 (90 %) 10 (77 %) 0.189
Data are presented as mean ± standard deviation, median and range or percent
AF atrial fibrillation, LA left atrial, LV left ventricle, PV pulmonary vein, PVI PV isolation, RA right atrial, TIA transient ischemic attack
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implantation for chronotropic incompetence. Early post-
operative atrial arrhythmias were documented in 35 % of
patients, most frequently first week postoperatively.
There were no intra- or postoperative deaths.
Late follow-up
Mean follow-up was 5 years (range, 1–7 years), and 42
out of 49 patients (87 %) completed 5 years of follow-up.
At 3, 6, 12, 24, 36, 48 and 60 months, freedom from AF
was seen in 82, 75, 59, 45, 41, 38, and 38 % of patients,
respectively. Five years postoperatively, 38 % of patients
were arrhythmia- and AAD-free (Fig. 2).
Nine patients (9 %) underwent a CARTO® ablation
procedure postoperatively. Five patients (6 %) in whom
PVI was achieved underwent CARTO® ablation, com-
pared with 5 (45 %) of those in whom PVI was not
achieved (RR - 7 [95 % CI 2,5 to 21,1], p = 0.001). Three
patients (3 %) required permanent pacemaker implant-
ation at late follow up. Two patients have been diagnosed
with sick sinus syndrome 30 and 36 months after the pro-
cedure; one patient underwent postoperative permanent
pacemaker implantation and atrioventricular-node abla-
tion for uncontrolled, symptomatic AF 26 months after
the procedure.
All patients with AAD-free sinus or atrially-paced
rhythm were off warfarin after six months after the pro-
cedure if CHA2DS2-VASc score was less than 2. Eight
patients out of sixteen (50 %) who were with SR were off
warfarin at five years follow up. Recurrent arrhythmias
were AF (75 %) and atrial flutter (25 %). Late postopera-
tive complications included pulmonary vein stenosis in
one patient (1 %) and bilateral lung hernia in one patient
(1 %). Pulmonary vein stenosis did not require any inter-
vention. There were no deaths at late follow-up.
Predictors of arrhythmia recurrence
In our patient cohort any of preoperative factors (age,
gender, AF duration, long term persistent AF, hyperten-
sion, vascular disease, diabetes mellitus, thyroid dys-
function, presence of heart failure, LA size) could not
predict reoccurrence of AF in Cox regression analysis
(p values above 0,05). Only pulmonary vein isolation
was related with SR at follow up (HR −3 [95 % CI 1,858
to 8,586], p = 0,001) in multivariate Cox regression ana-
lysis. At last follow up 47 (59 %) patients with PVI were in
sinus rhythm and only 1 (9 %) patient without PVI was in
SR. The log rank test was used to compare Kaplan – Meier
arrhythmia and AAD free survival curves and it confirmed
that AF recurrence was significantly less common in pa-
tients with achieved PVI (χ2 = 16, p < 0,005) (Fig. 3).
To determine predictors of success in restoring SR only
patients with achieved PVI were analyzed (80 patients).
Univariate predictors of long-term recurrent AF were
absence of division of ligament of Marshall (HR −2,3 [95 %
CI 1,035 to 5,202], p = 0,041), age (HR −1,058 [95 % CI
1,008 to 1,110], p = 0,023) and presence of thyroid dysfunc-
tion (HR −2,538 [95 % CI 1,090 to 6,191], p = 0,030). Multi-






























Fig. 2 Freedom from arrhythmia off AADs at follow-up. AAD antiarrhythmic drug
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tendency towards higher rates of SR at long term follow up
in patients with division of ligament of Marshall (HR - 2
[95 % CI 0.987 to 4,202], p = 0,067). Thirty five patients
(59 %) were in SR at last follow if PVI was achieved and
ligament of Marshall was divided up and 10 (48 %) patients
were in SR if ligament of Marshall was not divided.
The persistent AF outcome seems better than long
term persistent AF, but not significant statistically (χ2 =
1,075, p < 0,3), which might be secondary to small
patient number (Fig. 4).
Discussion
This study has some limitations. This is a single-center,
observational, retrospective study, and 13 % of patients
were lost to follow-up at 5 years. Implantable loop moni-
toring, which is more precise in diagnosing arrhythmias
and may have yielded different results [10], was not used
in our study.
Figure 2 shows that the effectiveness of the procedure
diminished with time; 12 months postoperatively, 59 %
of patients were arrhythmia- and AAD-free, but that
number declined to just 38 % at the 5-year follow-up
(Fig. 2). Our early results are comparable to those of
other centers [7, 11], where freedom from arrhythmias
and AADs was achieved in 72 % of patients at 12 months
in cases in which epicardial surgical ablation was used.
Long-term results have been reported only rarely, but
demonstrate a 5-year AF-free survival of 28 % for per-
sistent, and 29 % for longstanding AF if only PVI and
ganglionic plexus ablation was used [11]. Some studies
of catheter ablation report 20–45 % success with single
or multiple ablations for longstanding persistent AF at
the 5-year follow-up [12].
Epicardial surgical ablation is used in very different
ways and may vary from PVI only, to PVI with an add-
itional ablation line to the left atrial appendage and/or
ganglion ablation and/or right atrial ablation [7, 9, 13].
Most of the radiofrequency surgical ablations on beat-
ing heart are confined to left atrium [14, 15]. To date,
however, whether a right atrium ablation is necessary
remains controversial. There are numerous studies


































Fig. 3 Freedom from arrhythmia off AADs at follow-up in patients with and without achievement of PVI. AAD antiarrhythmic drug, PVI(+) pulmonary
vein isolation achieved, PVI(−) pulmonary vein isolation not achieved
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controlling persistent and longstanding persistent AF
than procedures confined to left atrium only [14–18].
Biatrial ablation strategy was chosen in our institution.
The right atrium lesion set (Fig. 1) could be safely
carried out using available bipolar radiofrequency de-
vice. Right atrial ablation may decrease the amount
of tissue hosting a variety of triggers for AF and
eliminate the substrate of atrial tachyarrhythmia’s,
which may improve the clinical outcome in patients
with non-paroxysmal AF [16, 19]. In general, how-
ever, epicardial ablation lacks a lesion across the
mitral valve isthmus [7] and the effect of our abla-
tion lines targeting the tricuspid isthmus is debat-
able. The endocardial Cox maze procedure enables
the creation of those lines and is more effective than
epicardial ablation [7]. The hybrid surgical ablation
as well enables the creation of those lines but overall
results seems to be similar to epicardial surgical
ablation [7].
The importance of ligament of Marshall to develop-
ment of AF is well described [20]. Ligament of Marshall
can be source of ectopic activity or reentry substrate AF
[21–23]. The division of ligament of Marshall is save and
feasible procedure though the left side chest access and
in our study was tendency towards higher rates of SR
after surgical ablation of persistent or long standing per-
sistent AF if PVI was achieved.
Conclusion
In conclusion, the lesion set used in our institution pro-
vides efficacy similar to that reported previously. It is
crucial to check and achieve PVI during surgical epicar-
dial ablation for atrial fibrilation. In our patient series
standard ablation with three applications from both
heart sides did not succeed in achieving PVI in 35
(38 %) patients. Failing to achieve PVI leads to very low
rates of SR restoration. Achieving PVI should be pur-
sued aggressively, and the procedure continued, until
PVI is achieved or patient safety is endangered. The
division of ligament of Marshall could contribute to im-
proved rates of SR restoration in patients with persistent
or long-standing persistent AF if PVI is achieved.
Consent
Written informed consent was obtained from the patients
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
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Fig. 4 Freedom from AF and off AADs at follow-up in patients with persistent and longstanding persistent AF. AAD antiarrhythmic drug, AF
atrial fibrillation
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